Shacham Sharon
SEC CIK 1588438 · EDGAR
BoughtSold
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
| 11 | Shacham Sharon | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 16:36 | 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Shacham Sharon | Dir | A - Grant | $0.00 | +9,366 | 9,366 | New | $0 | |
| D | 2022-03-31 | 2022-03-29 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | A - Grant | $0.00 | +60.0K | 958.1K | +7% | $0 |
| DI | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | A - Grant | $0.00 | +21.0K | 720.0K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | S - Sale | $10.24 | -6,226 | 898.1K | -0.7% | -$63.8K |
| DI | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | S - Sale | $10.24 | -6,226 | 713.8K | -0.9% | -$63.8K |
| I | 2022-02-22 | 2022-02-17 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | S - Sale | $12.12 | -9,079 | 699.0K | -1% | -$110.0K |
| 2022-02-22 | 2022-02-17 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | S - Sale | $12.12 | -9,088 | 904.4K | -1.0% | -$110.1K | |
| 2022-02-09 | 2022-02-07 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | S - Sale | $9.86 | -6,707 | 913.4K | -0.7% | -$66.1K | |
| I | 2022-02-09 | 2022-02-07 | KPTI | Karyopharm Therapeutics Inc. | Shacham Sharon | CSO | S - Sale | $9.86 | -6,764 | 708.1K | -0.9% | -$66.7K |
Purchase Sale Sale after option exercise All abbreviations